Alejandro Martínez-Pradeda

4PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 25, 2025
Real-World Safety Profile of Ibrutinib in Chronic Lymphocytic Leukemia: A Focus on Adverse Events, Discontinuations, and Effectiveness Outcomes.

Alejandro Martínez Pradeda, Pablo Feijoo Vilanova, Elena Fernández Gabriel

|Feb 26, 2025
Effect of Gender on Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Real-World Study.

Teresa Calleja-Chucla, Patricia Cordeiro González, Alejandro Martínez Pradeda

|Apr 27, 2024
Observational Study to Compare Biological Drug Concentration Quantification Techniques and Immunogenicity in Patients with Immune-Mediated Diseases.

Alejandro Martínez-Pradeda, Laida Elberdín, Ángeles Porta-Sánchez

|Feb 10, 2024
Analysing Early Diagnosis Strategies for HIV Infection: A Retrospective Study of Missed Diagnostic Opportunities.

Víctor Giménez-Arufe, Sandra Rotea-Salvo, Alejandro Martínez-Pradeda

Pageof 1

Frequent Collaborators

2 joint publications

Luis Margusino-Framiñán

1 joint publications

Teresa Calleja-Chucla

1 joint publications

Sonia Pértega-Díaz

1 joint publications

Pablo Feijoo Vilanova